|Videos|May 22, 2023
Interviews with Actylis at DCAT
Author(s)Actylis
KEY LEARNING OBJECTIVES
- Innovative API development capabilities
- Customized global GMP manufacturing capabilities
- Hybrid manufacturing and sourcing business model
Related Content
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
PharmTech Weekly Roundup—September 4, 2026
3
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
4
AAPS PharmSci 360: CMC Strategies, Part 1
5